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ISEI Abstract – 2 – Genetic prescriptions for health
Regulation of Immunological Pathways by MicroRNAs in Health and
Disease
WESSNER B
Institute of Sport Science & Research Platform Active Ageing; University of Vienna;
Vienna, Austria.
ABSTRACT
MicroRNAs (miRNAs) are small, non-coding, single stranded RNA molecules (19-24 nucleotides in
length) that influence mRNA or protein levels by promoting either mRNA degradation or by
preventing protein translation. In silico target prediction has revealed that they might regulate more
than two thirds of human genes therefore playing an important role in physiological as well as
pathophysiological processes (Ambros 2004; Lim, Lau et al. 2005). As such miRNAs have been
identified as mediators of biological processes such as inflammation, angiogenesis, mitochondrial
metabolism, cardiac and skeletal muscle contractile force generation and muscle hypertrophy and are
suggested to play a significant role in exercise immunology by influenceing important immunological
pathways such as the Nf-κB or the TGF-β signaling pathways (Wessner, Gryadunov-Masutti et al.
2010; Bronevetsky and Ansel 2013)
Besides their functional role within cells, significant levels of miRNAs were detected in serum and
other body fluids such as plasma, saliva, and urine. In serum they are remarkably stable due to their
association with RNA-binding proteins, exosomes or HDL. Given this stability and the fact that the
expressions of certain miRNAs are linked to specific tissues, expectations for the use of circulating
miRNA as non-invasive biomarkers for the diagnosis, prognosis and therapeutic appraisal of diseases
such as cancer, cardiac failure, diabetes mellitus, acute hepatitis but also inflammageing and muscle
damage after intense exercise are raised (Olivieri, Spazzafumo et al. 2012; Weiland, Gao et al. 2012)
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